NEUROCRINE BIOSCIENCES INC (NBIX)       126.81  +0.5 (+0.4%)

126.81  +0.5 (+0.4%)

US64125C1099 - Common Stock - After market: 126.81 0 (0%)

Buy % Consensus

78
Analysts have set a mean price target of 130.13. This target is 2.62% above the current price.
NBIX was analyzed by 34 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about NBIX.
In the previous month the buy percentage consensus was at a similar level.
NBIX was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 126.81102.01130.05130.13157.50 - -19.56% 2.56% 2.62% 24.20%

Up and Down Grades

Date Firm Action Rating
2022-11-14 Evercore ISI Group Downgrade Outperform -> In-Line
2022-11-03 Raymond James Maintains Outperform
2022-11-03 JP Morgan Maintains Overweight
2022-11-02 Cantor Fitzgerald Maintains Overweight
2022-11-02 Mizuho Maintains Neutral
2022-11-02 RBC Capital Maintains Sector Perform
2022-11-02 SVB Leerink Maintains Market Perform
2022-11-02 Wells Fargo Maintains Equal-Weight
2022-11-02 Morgan Stanley Maintains Equal-Weight
2022-11-02 Piper Sandler Maintains Neutral
2022-10-24 Citigroup Maintains Buy
2022-10-20 Mizuho Maintains Neutral
2022-10-11 UBS Initiate Buy
2022-09-26 Wells Fargo Initiate Equal-Weight
2022-08-08 Mizuho Maintains Neutral
2022-08-05 Barclays Maintains Overweight
2022-07-15 Morgan Stanley Maintains Equal-Weight
2022-04-12 Barclays Maintains Overweight
2022-03-03 Piper Sandler Downgrade Overweight -> Neutral
2022-02-25 Goldman Sachs Upgrade Neutral -> Buy
2022-02-14 Morgan Stanley Maintains Equal-Weight
2022-02-01 Morgan Stanley Maintains Equal-Weight
2022-01-20 Barclays Maintains Overweight
2022-01-18 RBC Capital Downgrade Outperform -> Sector Perform
2022-01-07 Morgan Stanley Maintains Equal-Weight
2021-12-08 Oppenheimer Maintains Outperform
2021-12-08 Citigroup Maintains Buy
2021-11-19 BMO Capital Initiate Underperform
2021-11-17 JP Morgan Upgrade Neutral -> Overweight
2021-11-02 Mizuho Maintains Neutral

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA